Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease

Therapeutic Advances in Respiratory Disease

Volumn 4, Issue 1, 2010, Pages 19-34

  Marwick, John A ^a   Chung, Kian Fan ^a   Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

allergy; asthma; chronic obstructive pulmonary disease; cystic fibrosis; idiopathic pulmonary fibrosis; inflammation; PI3K

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 5 (6 QUINOXALINYLMETHYLENE) 2,4 THIAZOLIDINEDIONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRUTON TYROSINE KINASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GLUCOCORTICOID; IBUPROFEN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LONG ACTING DRUG; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; RAC PROTEIN; RHO KINASE; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXO; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNINDEXED DRUG; WORTMANNIN;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ASTHMA; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYTOKINE RELEASE; DRUG COST; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TARGETING; ENZYME ACTIVATION; FIBROSING ALVEOLITIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; KIDNEY CARCINOMA; LEUKOCYTE FUNCTION; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; ISOENZYMES; LEUKOCYTES; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION;

EID: 76349087609     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809352792     Document Type: Review

References (115)

1. Afshar, R., Medoff, B.D. and Luster, A.D. ( 2008) Allergic asthma: a tale of many T cells. Clin Expe Allergy 38: 1847-1857.
2. Ali, K., Bilancio, A., Thomas, M., Pearce, W., Gilfillan, A.M., Tkaczyk, C. et al. (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.
3. Ali, K., Camps, M., Pearce, W.P., Ji, H., Ruckle, T., Kuehn, N. et al. (2008) Isoform-specific functions of phosphoinositide 3-kinases: p110delta but not p110gamma promotes optimal allergic responses in vivo. J Immunol 180: 2538-2544.
4. Bader, A.G., Kang, S., Zhao, L. and Vogt, P.K. ( 2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921-929.
5. Balla, T. ( 2009) Finding partners for PI3Kgamma: when 84 is better than 101. Sci Signal 2(7G): pe35.
6. Barnes, P.J. ( 2008a) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
7. Barnes, P.J. ( 2008b) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118: 3546-3556.
8. Barnes, P.J. and Adcock, I.M. (2009) Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905-1917.
9. Bhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P.J., Adcock, I. et al. (2008) Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63: 784-790.
10. Bilancio, A., Okkenhaug, K., Camps, M., Emery, J.L., Ruckle, T., Rommel, C. et al. (2006) Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 107: 642-650.
11. Bohnacker, T., Marone, R., Collmann, E., Calvez, R., Hirsch, E., Wymann, M.P. et al. (2009) PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cells. Sci Signal 2: ra27.
12. Boyce, J.A., Broide, D., Matsumoto, K. and Bochner, B.S. (2009) Advances in mechanisms of asthma, allergy, and immunology in 2008. J Allergy Clin Immunol 123: 569-574.
13. Bringardner, B.D., Baran, C.P., Eubank, T.D. and Marsh, C.B. ( 2008) The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 10: 287-301.
14. Burda, P., Padilla, S.M., Sarkar, S. and Emr, S.D. ( 2002) Retromer function in endosome-to-Golgi retrograde transport is regulated by the yeast Vps34 PtdIns 3-kinase. J Cell Sci 115: 3889-3900.
15. Cantley, L.C. ( 2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
16. Carrabino, S., Carpani, D., Livraghi, A., Di Cicco, M., Costantini, D., Copreni, E. et al. (2006) Dysregulated interleukin-8 secretion and NF-(kappa)B activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibros 5: 113-119.
17. Carson, J.D., Van-áaller, G., Lehr, R., Sinnamon, R.H., Kirkpatrick, R.B., Auger, K.R. et al. (2008) Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase. Biochem J 409: 519-524.
18. Chung, F., Barnes, N., Allen, M., Angus, R., Corris, P., Knox, A. et al. (2002) Assessing the burden of respiratory disease in the UK. Respir Med 96: 963-975.
19. Chung, K.F. and Adcock, I.M. ( 2008) Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31: 1334-1356.
20. Chung, K.F. and Barnes, P.J. ( 1999) Cytokines in asthma. Thorax 54: 825-857.
21. Ciraolo, E., Iezzi, M., Marone, R., Marengo, S., Curio, C., Costa, C. et al. (2008) Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 1: ra3.
22. Clayton, E., Bardi, G., Bell, S.E., Chantry, D., Downes, C.P., Gray, A., Humphries, L.A. et al. (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196: 753-763.
23. Condliffe, A.M., Davidson, K., Anderson, K.E., Ellson, C.D., Crabbe, T., Okkenhaug, K. et al. (2005) Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106: 1432-1440.
24. Cosio, M.G., Saetta, M. and Agusti, A. (2009) Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360: 2445-2454.
25. Del Prete, A., Vermi, W., Dander, E., Otero, K., Barberis, L., Luini, W. et al. (2004) Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J 23: 3505-3515.
26. Denley, A., Gymnopoulos, M., Kang, S., Mitchell, C. and Vogt, P.K. ( 2009) Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation. Mol Cancer Res 7: 1132-1138.
27. Duan, W., Guinaldo Datiles, A.M.K., Leung, B.P., Vlahos, C.J. and Wong, W.S.F. ( 2005) An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5: 495-502.
28. Engelman, J.A. ( 2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562.
29. Engelman, J.A., Luo, J. and Cantley, L.C. ( 2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
30. Ezeamuzie, C.I., Sukumaran, J. and Philips, E. ( 2001) Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in guinea pigs in vivo. Am J Respir Crit Care Med 164: 1633-1639.
31. Faivre, S., Kroemer, G. and Raymond, E. ( 2006) Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 5: 671-688.
32. Falasca, M., Hughes, W.E., Dominguez, V., Sala, G., Fostira, F., Fang, M.Q. et al. (2007) The role of phosphoinositide 3-kinase C2{alpha} in insulin signaling. J Biol Chem 282: 28226-28236.
33. Ferguson, G.J., Milne, L., Kulkarni, S., Sasaki, T., Walker, S., Andrews, S. et al. (2007) PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nat Cell Biol 9: 86-91.
34. Ferreira, A.M., Isaacs, H., Hayflick, J.S., Rogers, K.A. and Sandig, M. ( 2006) The p110+ isoform of PI3K differentially regulates beta1 and beta2 integrin-mediated monocyte adhesion and spreading and modulates diapedesis. Microcirculation 13: 439-456.
35. Foukas, L.C. ( 2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441: 366-370.
36. Freedman, S.D., Blanco, P.G., Zaman, M.M., Shea, J.C., Ollero, M. and Hopper, I.K. ( 2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350: 560-569.
37. Fruman, D.A. and Bismuth, G. (2009) Fine tuning the immune response with PI3K. Immunol Rev 228: 253-272.
38. Gaidarov, I., Zhao, Y. and Keen, J.H. ( 2005) Individual phosphoinositide 3-kinase C2alpha domain activities independently regulate clathrin function. J Biol Chem 280: 40766-40772.
39. Galli, S.J., Tsai, M. and Piliponsky, A.M. ( 2008) The development of allergic inflammation. Nature 454: 445-454.
40. Gould, H.J. and Sutton, B.J. ( 2008) IgE in allergy and asthma today. Nat Rev Immunol 8: 205-217.
41. Guo, H., Samarakoon, A., Vanhaesebroeck, B. and Malarkannan, S. ( 2008) The p110delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J Exp Med 205: 2419-2435.
42. Hakim-Rad, K., Metz, M. and Maurer, M. (2009) Mast cells: makers and breakers of allergic inflammation. Curr Opin Allergy Clin Immunol 9: 427-430.
43. Hallett, J.M., Leitch, A.E., Riley, N.A., Duffin, R., Haslett, C. and Rossi, A.G. ( 2008) Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci 29: 250-257.
44. Heit, B., Liu, L., Colarusso, P., Puri, K.D. and Kubes, P. ( 2008) PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP. J Cell Sci 121: 205-214.
45. Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P.J. et al. (2006) Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 174: 134-141.
46. Hirsch, E., Katanaev, V.L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L. et al. (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: 1049-1053.
47. Jarjour, N.N., Wilson, S.J., Koenig, S.M., Laviolette, M., Moore, W.C., Davis, W.B. et al. (2006) Control of airway inflammation maintained at a lower steroid dose with 100/50 (mu)g of fluticasone propionate/salmeterol. J Allergy Clin Immunol 118: 44-52.
48. Jatakanon, A., Uasuf, C., Maziak, W., Lim, S., Chung, K.F. and Banes, P.J. ( 1999) Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160: 1532-1539.
49. Ji, H., Rintelen, F., Waltzinger, C., Bertschy Meier, D., Bilancio, A., Pearce, W. et al. (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 110: 2940-2947.
50. Jia, S., Liu, Z., Zhang, S., Liu, P., Zhang, L., Lee, S.H. et al. (2008) Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454: 776-779.
51. Kang, S., Bader, A.G. and Vogt, P.K. ( 2005) Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci U S A 102: 802-807.
52. Karp, C.L., Flick, L.M., Park, K.W., Softic, S., Greer, T.M., Keledjian, R. et al. (2004) Defective lipoxinmediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 5: 388-392.
53. Kearley, J., Robinson, D.S. and Lloyd, C.M. ( 2008) CD4+CD25+regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122: 617-624.
54. Kim, M.S., Rodinger, M. and Gilfillan, A.M. ( 2008) The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol 29: 493-501.
55. Kiri, V.A., Soriano, J., Visick, G. and Fabbri, L. ( 2009) Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database. Prim Care Resp J: (Epub ahead of print).
56. Kok, K., Geering, B. and Vanhaesebroeck, B. (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34: 115-127.
57. Konstan, M.W. ( 2008) Ibuprofen therapy for cystic fibrosis lung disease: revisited. Curr Opin Pulm Med 14: 567-573.
58. Kuo, C.C., Lin, W.T., Liang, C.M. and Liang, S.M. ( 2006) Class I and III phosphatidylinositol 3–kinase play distinct roles in TLR signaling pathway. J Immunol 176: 5943-5949.
59. Kwak, Y.-G., Song, C.H., Yi, H.K., Hwang, P.H., Kim, J.-S., Lee, K.S. and Lee, Y.C. ( 2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111: 1083-1092.
60. Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M. et al. (2002) Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 16: 441-451.
61. Lee, K.S., Lee, H.K., Hayflick, J.S., Lee, Y.C. and Puri, K.D. ( 2006a) Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 20: 455-465.
62. Lee, K.S., Park, S.J., Kim, S.R., Min, K.H., Jin, S.M., Puri, K.D. and Lee, Y.C. ( 2006b) Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol 118: 403-409.
63. Leverrier, Y., Okkenhaug, K., Sawyer, C., Bilancio, A., Vanhaesebroeck, B. and Ridley, A.J. ( 2003) Class 1 phosphoinositide 3-kinase p110beta is required for apoptotic cell Fcgamma receptor-mediated phagocytosis by macrophages. J Biol Chem 278: 38437-38442.
64. Lewkowich, I.P., Herman, N.S., Schleifer, K.W., Dance, M.P., Chen, B.L., Dienger, K.M. et al. (2005) CD4+CD25+T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 202: 1549-1561.
65. Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A.V. and Wu, D. ( 2000) Roles of PLC-2 and -3 and PI3K in chemoattractant-mediated signal transduction. Science 287: 1046-1049.
66. Lim, D.H., Cho, J.Y., Song, D.J., Lee, S.Y., Miller, M. and Broide, D.H. (2009) PI3Kgamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol 296: L210-L219.
67. Lindsley, C.W., Barnett, S.F., Yaroschak, M., Bilodeau, M.T. and Layton, M.E. ( 2007) Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. Curr Top Med Chem 7: 1349-1363.
68. Liu, P., Cheng, H., Roberts, T.M. and Zhao, J.J. (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
69. Marone, R., Cmiljanovic, V., Giese, B. and Wymann, M.P. ( 2008) Targeting phosphoinositide 3-kinase- moving towards therapy. Biochim Biophys Prot Proteom 1784: 159-185.
70. Marwick, J.A., Caramori, G., Stevenson, C.S., Casolari, P., Jazrawi, E., Barnes, P.J. et al. (2009) Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med 179: 542-548.
71. Maus, U.A., Backi, M., Winter, C., Srivastava, M., Schwarz, M.K., Ruckle, T. et al. (2007) Importance of phosphoinositide 3-kinase {gamma} in the host defense against pneumococcal infection. Am J Respir Crit Care Med 175: 958-966.
72. Mehrad, B., Burdick, M.D. and Strieter, R.M. ( 2008) Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 41: 1708-1718.
73. Mishra, R.K., Scaife, J.E., Harb, Z., Gray, B.C., Djukanovic, R. and Dent, G. (2009) Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 60: 1204-1207.
74. Murray, C.S., Poletti, G., Kebadze, T., Morris, J., Woodcock, A., Johnston, S.L. et al. (2006) Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61: 376-382.
75. Naccache, P.H., Levasseur, S., Lachance, G., Chakravarti, S., Bourgoin, S.G. and McColl, S.R. ( 2000) Stimulation of Human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase gamma. J Biol Chem 275: 23636-23641.
76. Nashed, B., Zhang, T., Al-Alwan, M., Srinivasan, G., Halayko, A.J. and Okkenhaug, K. ( 2007) The role of phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 37: 416-424.
77. Nichols, D., Chmiel, J. and Berger, M. ( 2008) Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol 34: 146-162.
78. O'sullivan, B.P. and Freedman, S.D. ( 2009) Cystic fibrosis. Lancet 373: 1891-1904.
79. Okkenhaug, K. ( 2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297: 1031-1034.
80. Okkenhaug, K., Patton, D.T., Bilancio, A., Garcon, F., Rowan, W.C. and Vanhaesebroeck, B. ( 2006) The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 177: 5122-5128.
81. Okuzumi, T., Fiedler, D., Zhang, C., Gray, D.C., Aizenstein, B., Hoffman, R. et al. (2009) Inhibitor hijacking of Akt activation. Nat Chem Biol 5: 484-493.
82. Patton, D.T., Garden, O.A., Pearce, W.P., Clough, L.E., Monk, C.R., Leung, E. et al. (2006) Cutting edge: The phosphoinositide 3-kinase p110delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177: 6598-6602.
83. Pinho, V., Souza, D.G., Barsante, M.M., Hamer, F.P., De Freitas, M.S., Rossi, A.G. et al. (2005) Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J Leukoc Biol 77: 800-810.
84. Poolman, T.M., Ng, L.L., Farmer, P.B. and Manson, M.M. ( 2005) Inhibition of the respiratory burst by resveratrol in human monocytes: Correlation with inhibition of PI3K signaling. Free Rad Biol Med 39: 118-132.
85. Puri, K.D. ( 2004) Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 103: 3448-3456.
86. Puri, K.D., Doggett, T.A., Huang, C.Y., Douangpanya, J., Hayflick, J.S., Turner, M. et al. (2005) The role of endothelial PI3Kgamma activity in neutrophil trafficking. Blood 106: 150-157.
87. Reif, K., Okkenhaug, K., Sasaki, T., Penninger, J.M., Vanhaesebroeck, B. and Cyster, J.G. ( 2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173: 2236-2240.
88. Rock, M., Yoder, S., Hoskins, A., Ajayi, W.U., Sheller, J.R. and Dworski, R. (2009) Effect of allergen challenge on the percentage of natural killer T cells in patients with atopic asthma. Ann Allergy Asthma Immunol 102: 432-437.
89. Rommel, C., Camps, M. and Ji, H. ( 2007) PI3Kdelta and PI3Kgamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7: 191-201.
90. Ruckle, T., Schwarz, M.K. and Rommel, C. ( 2006) PI3K(gamma) inhibition: towards an ‘aspirin of the 21st century–? Nat Rev Drug Discov 5: 903-918.
91. Sadhu, C., Dick, K., Tino, W.T. and Staunton, D.E. ( 2003a) Selective role of PI3Kdelta in neutrophil inflammatory responses. Biochem Biophys Res Commun 308: 764-769.
92. Sadhu, C., Masinovsky, B., Dick, K., Sowell, C.G. and Staunton, D.E. ( 2003b) Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 170: 2647-2654.
93. Samuels, Y. and Ericson, K. ( 2006) Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18: 77-82.
94. Samuels, Y., Diaz, J., Schmidt-Kittler, O., Cummins, J.M., Delong, L., Cheong, I. et al. (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561-573.
95. Sasaki, A.T., Chun, C., Takeda, K. and Firtel, R.A. ( 2004) Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement. J Cell Biol 167: 505-518.
96. Sasaki, T., Irie-Sasaki, J., Jones, R.G., Olivera-dos-Santos, A.J., Stanford, W.L., Bolon, B. et al. (2000) Function of PI3K in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046.
97. Serhan, C.N. and Savill, J. ( 2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197.
98. Siddiqui, S., Hollins, F., Saha, S. and Brightling, C.E. ( 2007) Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur Respir J 30: 1043-1056.
99. Swat, W., Montgrain, V., Doggett, T.A., Douangpanya, J., Puri, K., Vermi, W. et al. (2006) Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood 107: 2415-2422.
100. Takeda, M., Ito, W., Tanabe, M., Ueki, S., Kato, H., Kihara, J. et al. (2009) Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. J Allergy Clin Immunol 123: 805-812.
101. Trivedi, S.G. ( 2007) Eosinophils in the pathogenesis of allergic airways disease. Cell mol Life Sci 64: 1269-1289.
102. Tuo, B.G., Wen, G., Zhang, Y., Liu, X., Wang, X., Liu, X. and Dong, H. ( 2009) Involvement of phosphatidylinositol 3-Kinase in cAMP- and cGMPinduced duodenal epithelial CFTR activation in mice. Am J Physiol Cell Physiol 00460.
103. van Gestel, Y., Hoeks, S., Sin, D., Huzeir, V., Stam, H., Mertens, F. et al. (2009) Chronic obstructive pulmonary disease and cancer mortality; the influence of statins. Thorax [Epub ahead of print].
104. Vanhaesebroeck, B., Leevers, S.J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P.C. et al. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Ann Rev Biochem 70: 535-602.
105. Vogt, P.K., Gymnopoulos, M. and Hart, J.R. (2009) PI 3-kinase and cancer: changing accents. Curr Opin Gen Dev 19: 12-17.
106. Wang, F., Herzmark, P., Weirner, O.D., Srinivasan, S., Servant, G. and Bourne, H.R. ( 2002) Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 4: 513-518.
107. Ward, S.G. and Marelliberg, F.M. (2009) Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem J 418: 13-27.
108. Wenzel, S.E. and Busse, W.W. ( 2007) Severe asthma: Lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 119: 14-21.
109. Wilkinson, T.M.A., Hurst, J.R., Perera, W.R., Wilks, M., Donaldson, G.C. and Wedzicha, J.A. ( 2006) Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 129: 317-324.
110. Wymann, M.P., Bjorklof, K., Calvez, R., Finan, P., Thomast, M., Trifileff, A. et al. (2003) Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans 31: 275-280.
111. Wymann, M.P. and Marone, R. ( 2005) Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr Opin Cell Biol 17: 141-149.
112. Wymann, M.P. and Schneiter, R. ( 2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9: 162-176.
113. Xia, H., Diebold, D., Nho, R., Perlman, D., Kleidon, J., Kahm, J. et al. (2008) Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med 205: 1659-1672.
114. Young, R.P., Hopkins, R.J., Christmas, T., Black, P.N., Metcalf, P. and Gamble, G.D. (2009) COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 34: 380-386.
115. Zhang, T.T., Okkenhaug, K., Nashed, B.F., Puri, K., Knight, Z.A., Shokat, K.M. et al. (2008) Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol 122: 811-819.